Consensus $1.35B. The company states: Merit Medical (MMSI) announced preliminary unaudited revenue in the range of approximately $1.355B to $1.357B for the year ended December 31, 2024, a projected increase of approximately 7.7% to 7.9% compared to revenue reported for the year ended December 31, 2023. Preliminary constant currency revenue for the year ended December 31, 2024, increased in the range of approximately 8.4% to 8.6% compared to the prior year period.”
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Barrington reveals best stocks ides for 2025
- Merit Medical announces FDA approval of WRAPSODY Cell-Impermeable Endoprosthesis
- Merit Medical Systems Announces Leadership Change Amid Investigation
- Merit Medical announces resignation of president Joseph Wright
- Reddit initiated, GE Vernova downgraded: Wall Street’s top analyst calls